The effect of organizational differentiation in football training on young football players. [PDF]
Størdal O, Dalen T, Lagestad P.
europepmc +1 more source
Black Fugitivity in the Sporting Workplace: The Story of Eniola Aluko
ABSTRACT Being a Black fugitive involves constant movement: to find and cultivate spaces of safety and hope. In this paper, I curate a sporting archive about the UK Black women's elite football player Eniola Aluko to read her as a Black fugitive. I demonstrate how she traversed a racist and anti‐Black sporting workplace—where she was unfairly demonized
Aarti Ratna
wiley +1 more source
Accelerometer-measured physical activity: comparing young adult football players and non-athletic peers. [PDF]
Jovanovic S +4 more
europepmc +1 more source
Unmothered at Work: Organizational Silence Around Reproductive Loss
ABSTRACT An identity transition refers to changes in self‐concept that can result from professional or personal shifts. Although organizations increasingly support institutionally legible and culturally normative nonwork transitions, others remain professionally stigmatized or culturally unspeakable.
Katrina M. Brownell
wiley +1 more source
Sleep quality and injury risk in adolescent football players: an amplified effect for high-risk athletes revealed by quantile regression. [PDF]
Li N, Quan Z, Pang D, Jin D.
europepmc +1 more source
Speaking Up and Standing Out: How Gendered Logics Shape Women's Self‐Advocacy at Work
ABSTRACT A widely held assumption is that women self‐advocate less than men. Our study challenges this view. Drawing on interviews with 71 men and women in a multinational company's leadership development pipeline and 10 HRM managers, we examine how women navigate self‐advocacy within gendered organizational logics.
Vedika Lal +4 more
wiley +1 more source
Lower-Body Muscle Volumes Can Explain Half of the Variance in Sprint Speed Between Collegiate American Football Players. [PDF]
Martin JA +6 more
europepmc +1 more source
Final Analysis of the Phase 1/2 Trial of Valoctocogene Roxaparvovec for Severe Haemophilia A
ABSTRACT Introduction Valoctocogene roxaparvovec is an adeno‐associated virus vector serotype 5 (AAV5)‐mediated gene therapy for severe haemophilia A (HA). Aim Report the final safety and efficacy results of the phase 1/2 trial of valoctocogene roxaparvovec. Methods An open‐label phase 1/2 trial (NCT02576795) enrolled adult males with severe HA (factor
Priyanka Raheja +9 more
wiley +1 more source

